These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 832268)
1. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. Pinedo HM; Zaharko DS; Bull J; Chabner BA Cancer Res; 1977 Feb; 37(2):445-50. PubMed ID: 832268 [TBL] [Abstract][Full Text] [Related]
2. Relative biochemical aspects of low and high doses of methotrexate in mice. Zaharko DS; Fung WP; Yang KH Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175 [TBL] [Abstract][Full Text] [Related]
3. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action. Strømhaug A; Warren DJ; Slørdal L Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815 [TBL] [Abstract][Full Text] [Related]
4. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. Pinedo HM; Zaharko DS; Bull JM; Chabner BA Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea. Schein PS; Bull JM; Doukas D; Hoth D Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400 [TBL] [Abstract][Full Text] [Related]
6. Resistance of human bone marrow CFUC to high-dose methotrexate cytotoxicity. Koizumi S; Yamagami M; Ueno Y; Miura M; Taniguchi N Exp Hematol; 1980 May; 8(5):635-40. PubMed ID: 7461061 [TBL] [Abstract][Full Text] [Related]
7. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays. Stiff PJ; Koester AR Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo. Laerum OD; Paukovits WR Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248 [TBL] [Abstract][Full Text] [Related]
9. The prevention of methotrexate toxicity by thymidine infusions in humans. Ensminger WD; Frei E Cancer Res; 1977 Jun; 37(6):1857-63. PubMed ID: 870189 [TBL] [Abstract][Full Text] [Related]
10. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy]. Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358 [TBL] [Abstract][Full Text] [Related]
11. From Plasma Kinetics to Cellular Pharmacology. Pinedo HM Oncologist; 1996; 1(4):232-233. PubMed ID: 10387994 [TBL] [Abstract][Full Text] [Related]
12. Evidence for early recruitment of granulocyte precursors during high-dose methotrexate infusions in mice. Pinedo HM; Chabner BA; Zaharko DS; Bull JM Blood; 1976 Aug; 48(2):301-7. PubMed ID: 949552 [TBL] [Abstract][Full Text] [Related]
13. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C. Ben-Ishay Z; Borenstein A; Sharon S; Prindull G Int J Cell Cloning; 1983 Oct; 1(5):343-59. PubMed ID: 6672102 [TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice. Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964 [TBL] [Abstract][Full Text] [Related]
16. Changes of bone marrow stromal cells (MSC) in mice after drug induced eradication of hematopoietic cells: in vitro effects on normal bone marrow. Ben-Ishay Z; Prindull G; Sharon S Biomed Pharmacother; 1982; 36(8-9):353-9. PubMed ID: 7182013 [TBL] [Abstract][Full Text] [Related]
17. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells. Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987 [TBL] [Abstract][Full Text] [Related]
18. Altered colony-forming activities of bone marrow hematopoietic stem cells in mice following short-term in vivo exposure to parathion. Gallicchio VS; Casale GP; Bartholomew PM; Watts TD Int J Cell Cloning; 1987 May; 5(3):231-41. PubMed ID: 3598245 [TBL] [Abstract][Full Text] [Related]
19. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy]. Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]